Computer-assisted analysis of cell proliferation markers in oral lesions

Acta Histochemica - Tập 109 - Trang 377-387 - 2007
Debora Barreto Teresa1, Karina Antunes Neves2, Carlos Benatti Neto2, Paula Andrea Gabrielli Fregonezi1, Maria Rita Brancini de Oliveira2, José Antonio Sampaio Zuanon2, Eduardo Antonio Donadi3, Celso Teixeira Mendes-Junior3, Christiane Pienna Soares1
1Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP), Rua Expedicionários do Brasil, 1621, 14 801 902 Araraquara, São Paulo, Brazil
2Department of Physiology and Pathology, Dental School, São Paulo State University (UNESP), Rua Humaitá, 1680, 14 801 903 Araraquara, São Paulo, Brazil
3Department of Clinical Medicine, Faculty of Medicine of Ribeirão Preto, University of São Paulo (USP), Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP, Brazil

Tài liệu tham khảo

Axéll, 1996, Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an International Symposium held in Uppsala, Sweden, May 18–21, J Oral Pathol Med, 25, 49, 10.1111/j.1600-0714.1996.tb00191.x

Ceccarelli, 2000, AgNORs in breast tumors, Micron, 31, 143, 10.1016/S0968-4328(99)00071-2

Chattopadhyay, 2002, AgNOR count as objective marker for dysplastic features in oral leukoplakia, J Oral Pathol Med, 31, 512, 10.1034/j.1600-0714.2002.00153.x

Derenzini, 2000, The AgNORs, Micron, 31, 117, 10.1016/S0968-4328(99)00067-0

Irazusta, 1998, The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa, Pathol Res Pract, 194, 33, 10.1016/S0344-0338(98)80009-5

Janczukowicz, 2003, The prognosis role of proliferation activity in human CNS tumors: the determination of AgNOR, PCNA and Ki-67 expression. Part 1: AgNOR expression in CNS tumors, Folia Neuropathol, 41, 97

Kahn, 1993, Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions, J Oral Pathol Med, 22, 257, 10.1111/j.1600-0714.1993.tb01067.x

Kannan, 1996, Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki-67, J Clin Pathol, 49, 170, 10.1136/mp.49.3.M170

Kill, 1996, Localization of the Ki-67 antigen within the nucleolus. Evidence for a fibrillarin-deficient region of the dense fibrillar component, J Cell Sci, 109, 1253, 10.1242/jcs.109.6.1253

Kuffer, 2002, Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN) – review, Oral Oncol, 38, 125, 10.1016/S1368-8375(01)00050-1

Le, 2003

Llewellyn, 2004, Factors associated with delay in presentation among younger patients with oral cancer, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 97, 707, 10.1016/j.tripleo.2004.01.007

Loukas, 2003, An image analysis-based approach for automated counting of cancer cell nuclei in tissue sections, Cytometry, 55A, 30, 10.1002/cyto.a.10060

Matsumoto, 1999, Predicting tumor metastasis in patients with oral cancer by means of the proliferation marker Ki67, J Oral Sci, 41, 53, 10.2334/josnusd.41.53

Munakata, 1994, A multilabeling technique for simultaneous demonstration and quantification of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue, J Histochem Cytochem, 42, 789, 10.1177/42.6.7514625

Öfner, 1995, Guideline of AgNOR quantitation – first update, Virchows Arch, 427, 341

Piattelli, 2002, Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity, J Oral Maxillofac Surg, 60, 532, 10.1053/joms.2002.31851

Piffko, 1997, Standardized AgNOR analysis of the invasive tumor front in oral squamous cell carcinomas, J Pathol, 182, 450, 10.1002/(SICI)1096-9896(199708)182:4<450::AID-PATH883>3.0.CO;2-V

Ray, 2003, Usefulness of AgNOR counts in diagnosing epithelial dysplasia, J Oral Pathol Med, 32, 71, 10.1034/j.1600-0714.2003.00053.x

Schwint, 1996, AgNOR mark epithelial foci in malignant transformation in hamster cheek pouch carcinogenesis, J Oral Pathol Med, 25, 20, 10.1111/j.1600-0714.1996.tb01218.x

Silverman, 1996, Leucoplakia, dysplasia, and malignant transformation, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82, 117, 10.1016/S1079-2104(96)80209-5

Sittel, 1999, Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity, Oral Oncol, 35, 583, 10.1016/S1368-8375(99)00041-X

Spolidorio, 2002, Evaluation of argyrophilic nucleolar organizer regions in oral tumor progression, Micron, 33, 605, 10.1016/S0968-4328(02)00031-8

Tipoe, 1996, The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium, Eur J Cancer B Oral Oncol, 32B, 24, 10.1016/0964-1955(95)00049-6

Treré, 2000, AgNOR staining and quantification, Micron, 31, 127, 10.1016/S0968-4328(99)00069-4

Van Der Waal, 2002, Oral leukoplakia: a proposal for uniform reporting, Oral Oncol, 38, 521, 10.1016/S1368-8375(01)00125-7

Warnakulasuriya, 1995, Epithelial cell kinetics in oral leukoplakia, J Oral Pathol Med, 24, 165, 10.1111/j.1600-0714.1995.tb01159.x